Literature DB >> 31077015

Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

S M Matt1, P J Gaskill2.   

Abstract

Dopamine is well recognized as a neurotransmitter in the brain, and regulates critical functions in a variety of peripheral systems. Growing research has also shown that dopamine acts as an important regulator of immune function. Many immune cells express dopamine receptors and other dopamine related proteins, enabling them to actively respond to dopamine and suggesting that dopaminergic immunoregulation is an important part of proper immune function. A detailed understanding of the physiological concentrations of dopamine in specific regions of the human body, particularly in peripheral systems, is critical to the development of hypotheses and experiments examining the effects of physiologically relevant dopamine concentrations on immune cells. Unfortunately, the dopamine concentrations to which these immune cells would be exposed in different anatomical regions are not clear. To address this issue, this comprehensive review details the current information regarding concentrations of dopamine found in both the central nervous system and in many regions of the periphery. In addition, we discuss the immune cells present in each region, and how these could interact with dopamine in each compartment described. Finally, the review briefly addresses how changes in these dopamine concentrations could influence immune cell dysfunction in several disease states including Parkinson's disease, multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease, as well as the collection of pathologies, cognitive and motor symptoms associated with HIV infection in the central nervous system, known as NeuroHIV. These data will improve our understanding of the interactions between the dopaminergic and immune systems during both homeostatic function and in disease, clarify the effects of existing dopaminergic drugs and promote the creation of new therapeutic strategies based on manipulating immune function through dopaminergic signaling. Graphical Abstract.

Entities:  

Keywords:  Catecholamine; Dopamine; Drug abuse; Immunopharmacology; Neuroimmunology; Neuropathogenesis

Mesh:

Substances:

Year:  2019        PMID: 31077015      PMCID: PMC6842680          DOI: 10.1007/s11481-019-09851-4

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  594 in total

1.  Acute and chronic dopamine dynamics in a nonhuman primate model of recreational cocaine use.

Authors:  C W Bradberry
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

Review 2.  Neurotransmission in the carotid body: transmitters and modulators between glomus cells and petrosal ganglion nerve terminals.

Authors:  Rodrigo Iturriaga; Julio Alcayaga
Journal:  Brain Res Brain Res Rev       Date:  2004-12

3.  D3 dopamine receptor mRNA is elevated in T cells of schizophrenic patients whereas D4 dopamine receptor mRNA is reduced in CD4+ -T cells.

Authors:  Eva-Maria Boneberg; Elisabeth von Seydlitz; Karl Pröpster; Hans Watzl; Brigitte Rockstroh; Harald Illges
Journal:  J Neuroimmunol       Date:  2005-12-27       Impact factor: 3.478

4.  Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: relevance to gastrointestinal dysfunctions in Parkinson's disease.

Authors:  G Levandis; B Balestra; F Siani; V Rizzo; C Ghezzi; G Ambrosi; S Cerri; A Bonizzi; R Vicini; M Vairetti; A Ferrigno; O Pastoris; F Blandini
Journal:  Neurogastroenterol Motil       Date:  2015-10-03       Impact factor: 3.598

Review 5.  Theodore Cooper Lecture: Renal dopamine system: paracrine regulator of sodium homeostasis and blood pressure.

Authors:  R M Carey
Journal:  Hypertension       Date:  2001-09       Impact factor: 10.190

6.  Profiles of secreted neuropeptides and catecholamines illustrate similarities and differences in response to stimulation by distinct secretagogues.

Authors:  Sonia Podvin; Richard Bundey; Thomas Toneff; Michael Ziegler; Vivian Hook
Journal:  Mol Cell Neurosci       Date:  2015-06-16       Impact factor: 4.314

Review 7.  Functions and imaging of mast cell and neural axis of the gut.

Authors:  Michael Schemann; Michael Camilleri
Journal:  Gastroenterology       Date:  2013-01-24       Impact factor: 22.682

Review 8.  Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models.

Authors:  C Pellegrini; R Colucci; L Antonioli; E Barocelli; V Ballabeni; N Bernardini; C Blandizzi; W J de Jonge; M Fornai
Journal:  Neurogastroenterol Motil       Date:  2016-09-09       Impact factor: 3.598

9.  Damage to the Brain Serotonergic System Increases the Expression of Liver Cytochrome P450.

Authors:  Marta Rysz; Ewa Bromek; Anna Haduch; Anna Sadakierska-Chudy; Władysława A Daniel
Journal:  Drug Metab Dispos       Date:  2015-06-09       Impact factor: 3.922

10.  Amperometric detection of stimulus-induced quantal release of catecholamines from cultured superior cervical ganglion neurons.

Authors:  Z Zhou; S Misler
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

View more
  45 in total

Review 1.  Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.

Authors:  Stephanie M Matt; Peter J Gaskill
Journal:  Brain Res       Date:  2019-08-21       Impact factor: 3.252

2.  Dopamine increases HIV entry into macrophages by increasing calcium release via an alternative signaling pathway.

Authors:  E A Nickoloff-Bybel; P Mackie; K Runner; S M Matt; H Khoshbouei; P J Gaskill
Journal:  Brain Behav Immun       Date:  2019-08-27       Impact factor: 7.217

3.  Dopaminergic and Adrenergic Pathways as Targets for Drug Repurposing in the Neuroimmune Network.

Authors:  Marco Cosentino
Journal:  J Neuroimmune Pharmacol       Date:  2020-02-26       Impact factor: 4.147

Review 4.  Vasopressor therapy in critically ill patients with shock.

Authors:  James A Russell
Journal:  Intensive Care Med       Date:  2019-10-23       Impact factor: 17.440

5.  A novel approach to study markers of dopamine signaling in peripheral immune cells.

Authors:  Adithya Gopinath; Andria Doty; Phillip M Mackie; Basil Hashimi; Madison Francis; Leila Saadatpour; Kaustuv Saha; Gerry Shaw; Adolfo Ramirez-Zamora; Michael S Okun; Wolfgang J Streit; Habibeh Khoshbouei
Journal:  J Immunol Methods       Date:  2019-10-18       Impact factor: 2.303

Review 6.  Dopaminergic Pathways in Obesity-Associated Inflammation.

Authors:  Fernanda Leite; Laura Ribeiro
Journal:  J Neuroimmune Pharmacol       Date:  2019-07-17       Impact factor: 4.147

7.  Dopaminergic Receptors as Neuroimmune Mediators in Experimental Autoimmune Encephalomyelitis.

Authors:  E C D Gonçalves; V Lieberknecht; V V Horewicz; B D Rabelo; F A Felipetti; A L S Rodrigues; D F Martins; R C Dutra
Journal:  Mol Neurobiol       Date:  2021-08-25       Impact factor: 5.590

8.  Dopamine suppresses osteoclast differentiation via cAMP/PKA/CREB pathway.

Authors:  Lufei Wang; Lichi Han; Peng Xue; Xiangxiang Hu; Sing-Wai Wong; Meng Deng; Henry C Tseng; Bo-Wen Huang; Ching-Chang Ko
Journal:  Cell Signal       Date:  2020-11-24       Impact factor: 4.315

9.  Dopamine Levels Induced by Substance Abuse Alter Efficacy of Maraviroc and Expression of CCR5 Conformations on Myeloid Cells: Implications for NeuroHIV.

Authors:  Stephanie M Matt; Emily A Nickoloff-Bybel; Yi Rong; Kaitlyn Runner; Hannah Johnson; Margaret H O'Connor; Elias K Haddad; Peter J Gaskill
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

10.  Immune System and Neuroinflammation in Idiopathic Parkinson's Disease: Association Analysis of Genetic Variants and miRNAs Interactions.

Authors:  Claudia Strafella; Valerio Caputo; Andrea Termine; Francesca Assogna; Clelia Pellicano; Francesco E Pontieri; Lucia Macchiusi; Giulietta Minozzi; Stefano Gambardella; Diego Centonze; Paola Bossù; Gianfranco Spalletta; Carlo Caltagirone; Emiliano Giardina; Raffaella Cascella
Journal:  Front Genet       Date:  2021-06-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.